- Conditions
- Alzheimer Disease, Mild Cognitive Impairment
- Interventions
- Brivaracetam
- Drug
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 45 Years to 70 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Jan 26, 2026 · Synced May 21, 2026, 10:43 PM EDT